Diagnostic News and Research

RSS

Quality and stress-free MRI service from Weiss Medical Associates

An MRI (Magnetic Resonance Image) diagnostic clinic is an unlikely place to expect a warm, fuzzy, friendly staff. Having an MRI is serious business, often related to traumatic or orthopedic injuries, brain diseases or dental TMJ problems.

13 Nov 2009

PKCI/HINT1 gene associated with mood regulation

Removing the PKCI/HINT1 gene from mice has an anti-depressant-like and anxiolytic-like effect. Researchers writing in the open access journal BMC Neuroscience applied a battery of behavioral tests to the PKCI/HINT1 knockout animals, concluding that the deleted gene may have an important role in mood regulation.

13 Nov 2009

Cardiac Science and Cambridge Heart team up to develop MTWA module

Cardiac Science Corporation [NASDAQ: CSCX], a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, and Cambridge Heart, Inc., [OTCBB-CAMH], a developer of noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest, today announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23, 2009.

13 Nov 2009

CMS approves FDG PET for initial staging of cervical cancer

SNM applauds the Centers for Medicare & Medicaid Services- (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions.

13 Nov 2009

Mouth: A diagnostic indicator for general health

The mouth or oral cavity area is an excellent indicator of the whole body's health, says Mao, who is the chair of the new Department of Oncology and Diagnostic Sciences at the School.

13 Nov 2009

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

AvidBiotics Corp. announced the issuance of foundational patents encompassing a completely novel mechanism for generating massive diversity within precisely targeted sites of protein-encoding DNA sequences. The technology platform is referred to as Diversity Generating Retroelements (DGR) and patents were issued in both the United States (#7,585,957) and in Europe (#1,173,995). UCLA and AvidBiotics Corp are co-assignees of the patents, and AvidBiotics holds exclusive, worldwide rights to the patents from UCLA.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science’s “Innovation of the Year.” This prestigious honor, part of the publication’s annual “Best of What’s New Awards,” highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.

12 Nov 2009

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Vermillion, Inc., a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer.

12 Nov 2009

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Arrayit Corporation announced today that the company's majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most intensive marketing campaign in the company's thirteen-year history. The company is currently developing several diagnostic tests that will provide early detection for cancers, neurodegenerative diseases and other disease states.

12 Nov 2009

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Spectral Diagnostics Inc., today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award

Signature Genomics, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, today announced company co-founders Dr. Lisa G. Shaffer, Ph.D., and Dr. Bassem A. Bejjani, M.D. have received the 2009 Inland Northwest Catalyst Award for Innovators of the Year.

12 Nov 2009

U.S. Patent and Trademark Office awards new patent for Ryogen

Ryogen LLC, a genomic start-up company, has been awarded a new patent titled “Isolated Genomic Polynucleotide Fragments from Chromosome 7”.

12 Nov 2009

Hualapai Mountain Medical Center receives licensure by the Arizona Department of Health Services

MedCath Corporation, a healthcare provider focused on high acuity healthcare services, today announced it has received licensure by the Arizona Department of Health Services and accreditation by The Joint Commission for its new 70-bed Hualapai Mountain Medical Center in Kingman, Ariz, which opened October 15th.

12 Nov 2009

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results as at and for the three-month and nine-month periods ended September 30, 2009.

11 Nov 2009

Report on the U.S. Government's drive for comparative effectiveness research

MarketResearch.com has announced the addition of GlobalData's new report "The US Government's Financial Support to Push Comparative Effectiveness Research," to their collection of Healthcare market reports.

11 Nov 2009

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

11 Nov 2009

Men more likely to abandon partners diagnosed with cancer

A woman is six times more likely to be separated or divorced soon after a diagnosis of cancer or multiple sclerosis than if a man in the relationship is the patient, according to a study that examined the role gender played in so-called "partner abandonment." The study also found that the longer the marriage the more likely it would remain intact.

11 Nov 2009

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.

11 Nov 2009

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

When a fetus is smaller than expected for the number of weeks of pregnancy, due to associated problems like a poorly developed heart, health concerns as severe as brain damage can result.

11 Nov 2009

Diagnostic News and Research

Quality and stress-free MRI service from Weiss Medical Associates

PKCI/HINT1 gene associated with mood regulation

Cardiac Science and Cambridge Heart team up to develop MTWA module

CMS approves FDG PET for initial staging of cervical cancer

Mouth: A diagnostic indicator for general health

AvidBiotics granted U.S. and European patents concerning its DGR technology platform

CDC expected to revise estimated number of U.S. H1N1 deaths

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award

U.S. Patent and Trademark Office awards new patent for Ryogen

Hualapai Mountain Medical Center receives licensure by the Arizona Department of Health Services

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

Report on the U.S. Government's drive for comparative effectiveness research

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

Men more likely to abandon partners diagnosed with cancer

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News